S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave

Ascendis Pharma A/S (ASND) SEC Filings & 10K Form

$140.17
-0.72 (-0.51%)
(As of 04/19/2024 ET)

Recent Ascendis Pharma A/S SEC Filings

DateFilerForm TypeView
03/07/2024
10:31 AM
Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
8:39 PM
Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
8:47 AM
Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:04 AM
Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
7:14 AM
Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:52 AM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:37 AM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:54 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:07 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:17 PM
Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:36 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
1:24 PM
Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
10:00 AM
Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:13 PM
Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:21 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:17 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
4:45 PM
Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:17 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:14 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:15 PM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
4:16 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
10:40 AM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:17 AM
Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/13/2024
10:57 AM
Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/12/2024
5:12 AM
Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
Form SC 13G/A
02/09/2024
1:17 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
7:35 AM
Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/07/2024
3:15 PM
Ascendis Pharma A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/02/2024
12:18 PM
Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
01/29/2024
7:36 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
5:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
5:08 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
5:08 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
7:30 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
7:32 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
1:53 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2023
3:20 PM
Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
5:04 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2023
7:30 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2023
3:06 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2023
3:26 PM
Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
09/20/2023
2:47 PM
Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:10 PM
Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:34 PM
Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:19 PM
Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
11:42 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
2:12 PM
Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
8:15 AM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144/A
09/08/2023
7:00 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:40 PM
Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
3:14 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
3:15 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
3:05 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
3:09 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2023
3:02 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
7:00 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
7:05 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
11:01 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
7:35 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
5:04 AM
Ascendis Pharma A/S (Filer)
Form SD
Specialized Disclosure Report  
05/10/2023
4:16 PM
Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2023
7:30 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ASND) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners